New Norwegian biotechnology could pave the way for development of more efficient drugs The now patented technology goes under the name “Super Albumin” and is based on the human protein albumin. 15 years of studying this substance may now yield concrete results.
Multi-drug resistant bacteria: When the immune system during COVID-19 is attacked from two fronts SHARE YOUR SCIENCE: Norwegian COVID-19 patients who get a secondary bacterial infection leading to pneumonia, are better equipped in their struggle against this than Italian patients. Are we doing enough to find new technology against multi-drug resistant bacteria?
Experts want to free medical research and healthcare from ties to the commercial pharmaceutical industry Pharmaceutical companies are behind much of the research on new drugs and have an influence on medical education and guidelines for treatments. It’s time for this to change, a group of international scientists says.
No improvement in chronic fatigue with new medicine Researchers hoped they had found the first effective drug against CFS, but the patients ended up just as exhausted as before.